SUSAN DEEN: Open Payments
NPI 1497536866 · BLACKSHEAR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 24 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $0 · 2025 $525
Food & beverage: $440Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $200 |
| Janssen Biotech, Inc. | 5 | $157 |
| Madrigal Pharmaceuticals | 3 | $71 |
| Novo Nordisk Inc | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Celltrion USA Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 2 | $13 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, Wegovy, LINZESS, XIFAXAN, ENTYVIO, VEGZELMA.
Industry payments across GA — which companies pay providers there.
